Malattia di Batten (Italian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Malattia di Batten" in Italian language version.

refsWebsite

Global rank Italian rank

56nih.gov

4^th place

9^th place

23doi.org

2^nd place

7^th place

16oadoi.org

799^th place

22^nd place

8archive.org

6^th place

8^th place

4web.archive.org

1^st place

3ucl.ac.uk

1,306^th place

3,226^th place

1jncl.fi

low place

1ncl-netz.de

low place

1rxlist.com

7,927^th place

low place

1nejm.org

2,374^th place

1,283^rd place

1clinicaltrials.gov

5,225^th place

5,296^th place

1cornell.edu

332^nd place

894^th place

1portlandtribune.com

8,169^th place

low place

1technologyreview.com

1,943^rd place

7,684^th place

1webcitation.org

24^th place

48^th place

archive.org

Miao N, Levin SW, Baker EH, et al., Children with infantile neuronal ceroid lipofuscinosis have an increased risk of hypothermia and bradycardia during anesthesia, in Anesth. Analg., vol. 109, n. 2, agosto 2009, pp. 372–8, DOI:10.1213/ane.0b013e3181aa6e95, PMC 2743022, PMID 19608805. URL consultato il 5 agosto 2010.
RM. Taylor, BR. Farrow, Ceroid-lipofuscinosis in border collie dogs., in Acta Neuropathol, vol. 75, n. 6, 1988, pp. 627-31, PMID 3376765.
F. Lingaas, T. Aarskaug; M. Sletten; I. Bjerkås; U. Grimholt; L. Moe; RK. Juneja; AN. Wilton; F. Galibert; NG. Holmes; G. Dolf, Genetic markers linked to neuronal ceroid lipofuscinosis in English setter dogs., in Anim Genet, vol. 29, n. 5, ottobre 1998, pp. 371-6, PMID 9800325.
D. Ramirez-Montealegre, PG. Rothberg; DA. Pearce, Another disorder finds its gene., in Brain, vol. 129, Pt 6, giugno 2006, pp. 1353-6, DOI:10.1093/brain/awl132, PMID 16738059.
C. Hartzell, Z. Qu; I. Putzier; L. Artinian; LT. Chien; Y. Cui, Looking chloride channels straight in the eye: bestrophins, lipofuscinosis, and retinal degeneration., in Physiology (Bethesda), vol. 20, ottobre 2005, pp. 292-302, DOI:10.1152/physiol.00021.2005, PMID 16174869.
G. Anderson, VV. Smith; M. Malone; NJ. Sebire, Blood film examination for vacuolated lymphocytes in the diagnosis of metabolic disorders; retrospective experience of more than 2,500 cases from a single centre., in J Clin Pathol, vol. 58, n. 12, dicembre 2005, pp. 1305-10, DOI:10.1136/jcp.2005.027045, PMID 16311352.
RS. Howard, RW. Orrell, Management of motor neurone disease., in Postgrad Med J, vol. 78, n. 926, dicembre 2002, pp. 736-41, PMID 12509691.
G. Gigler, K. Móricz; M. Agoston; A. Simó; M. Albert; A. Benedek; G. Kapus; S. Kertész; M. Vegh; J. Barkóczy; B. Markó, Neuroprotective and anticonvulsant effects of EGIS-8332, a non-competitive AMPA receptor antagonist, in a range of animal models., in Br J Pharmacol, vol. 152, n. 1, settembre 2007, pp. 151-60, DOI:10.1038/sj.bjp.0707362, PMID 17603549.

clinicaltrials.gov

Clinical Trial: Safety Study of a Gene Transfer Vector for Children With Late Infantile Neuronal Ceroid Lipofuscinosis, su clinicaltrials.gov. URL consultato l'8 giugno 2007.

cornell.edu

news.cornell.edu

Cornell Chronicle: Gene therapy for Batten D9isease, su Cornell Chronicle.

doi.org

dx.doi.org

Neuronal ceroid lipofuscinoses therapeutic strategies: Past, present and future, DOI:10.1016/j.bbadis.2006.08.004.
Rakheja D, Narayan SB, Bennett MJ, Juvenile neuronal ceroid-lipofuscinosis (Batten disease): a brief review and update, in Curr. Mol. Med., vol. 7, n. 6, settembre 2007, pp. 603–8, DOI:10.2174/156652407781695729, PMID 17896996. URL consultato il 1º novembre 2018 (archiviato dall'url originale il 15 aprile 2009).
Experimental Neurology : Moving towards therapies for Juvenile Batten disease?, DOI:10.1016/j.expneurol.2008.02.016.
Miao N, Levin SW, Baker EH, et al., Children with infantile neuronal ceroid lipofuscinosis have an increased risk of hypothermia and bradycardia during anesthesia, in Anesth. Analg., vol. 109, n. 2, agosto 2009, pp. 372–8, DOI:10.1213/ane.0b013e3181aa6e95, PMC 2743022, PMID 19608805. URL consultato il 5 agosto 2010.
DP. O'Brien, ML. Katz, Neuronal ceroid lipofuscinosis in 3 Australian shepherd littermates., in J Vet Intern Med, vol. 22, n. 2, pp. 472-5, DOI:10.1111/j.1939-1676.2008.0079.x, PMID 18371036.
C. Drögemüller, A. Wöhlke; O. Distl, Evaluation of the canine TPP1 gene as a candidate for neuronal ceroid lipofuscinosis in Tibetan Terrier and Polish Owczarek Nizinny dogs., in Anim Genet, vol. 36, n. 2, aprile 2005, pp. 178-9, DOI:10.1111/j.1365-2052.2005.01254.x, PMID 15771740.
SA. Melville, CL. Wilson; CS. Chiang; VP. Studdert; F. Lingaas; AN. Wilton, A mutation in canine CLN5 causes neuronal ceroid lipofuscinosis in Border collie dogs., in Genomics, vol. 86, n. 3, settembre 2005, pp. 287-94, DOI:10.1016/j.ygeno.2005.06.005, PMID 16033706.
RM. Taylor, BR. Farrow, Ceroid lipofuscinosis in the border collie dog: retinal lesions in an animal model of juvenile Batten disease., in Am J Med Genet, vol. 42, n. 4, febbraio 1992, pp. 622-7, DOI:10.1002/ajmg.1320420438, PMID 1319117.
N. Koppang, English setter model and juvenile ceroid-lipofuscinosis in man., in Am J Med Genet, vol. 42, n. 4, febbraio 1992, pp. 599-604, DOI:10.1002/ajmg.1320420434, PMID 1609842.
D. Ramirez-Montealegre, PG. Rothberg; DA. Pearce, Another disorder finds its gene., in Brain, vol. 129, Pt 6, giugno 2006, pp. 1353-6, DOI:10.1093/brain/awl132, PMID 16738059.
C. Hartzell, Z. Qu; I. Putzier; L. Artinian; LT. Chien; Y. Cui, Looking chloride channels straight in the eye: bestrophins, lipofuscinosis, and retinal degeneration., in Physiology (Bethesda), vol. 20, ottobre 2005, pp. 292-302, DOI:10.1152/physiol.00021.2005, PMID 16174869.
G. Anderson, VV. Smith; M. Malone; NJ. Sebire, Blood film examination for vacuolated lymphocytes in the diagnosis of metabolic disorders; retrospective experience of more than 2,500 cases from a single centre., in J Clin Pathol, vol. 58, n. 12, dicembre 2005, pp. 1305-10, DOI:10.1136/jcp.2005.027045, PMID 16311352.
(EN) Jinkuk Kim, Chunguang Hu e Christelle Moufawad El Achkar, Patient-Customized Oligonucleotide Therapy for a Rare Genetic Disease, in New England Journal of Medicine, 9 ottobre 2019, pp. NEJMoa1813279, DOI:10.1056/NEJMoa1813279. URL consultato l'11 ottobre 2019.
S. Worgall, D. Sondhi; NR. Hackett; B. Kosofsky; MV. Kekatpure; N. Neyzi; JP. Dyke; D. Ballon; L. Heier; BM. Greenwald; P. Christos, Treatment of late infantile neuronal ceroid lipofuscinosis by CNS administration of a serotype 2 adeno-associated virus expressing CLN2 cDNA., in Hum Gene Ther, vol. 19, n. 5, maggio 2008, pp. 463-74, DOI:10.1089/hum.2008.022, PMID 18473686.
JD. Cooper, Moving towards therapies for juvenile Batten disease?, in Exp Neurol, vol. 211, n. 2, giugno 2008, pp. 329-31, DOI:10.1016/j.expneurol.2008.02.016, PMID 18400221.
AD. Kovács, DA. Pearce, Attenuation of AMPA receptor activity improves motor skills in a mouse model of juvenile Batten disease., in Exp Neurol, vol. 209, n. 1, gennaio 2008, pp. 288-91, DOI:10.1016/j.expneurol.2007.09.012, PMID 17963751.
G. Gigler, K. Móricz; M. Agoston; A. Simó; M. Albert; A. Benedek; G. Kapus; S. Kertész; M. Vegh; J. Barkóczy; B. Markó, Neuroprotective and anticonvulsant effects of EGIS-8332, a non-competitive AMPA receptor antagonist, in a range of animal models., in Br J Pharmacol, vol. 152, n. 1, settembre 2007, pp. 151-60, DOI:10.1038/sj.bjp.0707362, PMID 17603549.
PK. Aujla, MR. Fetell; FE. Jensen, Talampanel suppresses the acute and chronic effects of seizures in a rodent neonatal seizure model., in Epilepsia, vol. 50, n. 4, aprile 2009, pp. 694-701, DOI:10.1111/j.1528-1167.2008.01947.x, PMID 19220413.
SN. Rakhade, C. Zhou; PK. Aujla; R. Fishman; NJ. Sucher; FE. Jensen, Early alterations of AMPA receptors mediate synaptic potentiation induced by neonatal seizures., in J Neurosci, vol. 28, n. 32, agosto 2008, pp. 7979-90, DOI:10.1523/JNEUROSCI.1734-08.2008, PMID 18685023.
JF. Howes, C. Bell, Talampanel., in Neurotherapeutics, vol. 4, n. 1, gennaio 2007, pp. 126-9, DOI:10.1016/j.nurt.2006.11.001, PMID 17199027.
RM. Pascuzzi, J. Shefner; AS. Chappell; JS. Bjerke; R. Tamura; V. Chaudhry; L. Clawson; L. Haas; JD. Rothstein, A phase II trial of talampanel in subjects with amyotrophic lateral sclerosis., in Amyotroph Lateral Scler, vol. 11, n. 3, maggio 2010, pp. 266-71, DOI:10.3109/17482960903307805, PMID 19961264.
BJ. Traynor, L. Bruijn; R. Conwit; F. Beal; G. O'Neill; SC. Fagan; ME. Cudkowicz, Neuroprotective agents for clinical trials in ALS: a systematic assessment., in Neurology, vol. 67, n. 1, luglio 2006, pp. 20-7, DOI:10.1212/01.wnl.0000223353.34006.54, PMID 16832072.
JY. Lu, SL. Hofmann, Inefficient cleavage of palmitoyl-protein thioesterase (PPT) substrates by aminothiols: implications for treatment of infantile neuronal ceroid lipofuscinosis., in J Inherit Metab Dis, vol. 29, n. 1, febbraio 2006, pp. 119-26, DOI:10.1007/s10545-006-0225-z, PMID 16601878.

jncl.fi

NCL, su jncl.fi. URL consultato il 31 luglio 2010.

ncl-netz.de

NCL-Netz, Informationen rund um NCL, su ncl-netz.de. URL consultato il 1º agosto 2010.

nejm.org

(EN) Jinkuk Kim, Chunguang Hu e Christelle Moufawad El Achkar, Patient-Customized Oligonucleotide Therapy for a Rare Genetic Disease, in New England Journal of Medicine, 9 ottobre 2019, pp. NEJMoa1813279, DOI:10.1056/NEJMoa1813279. URL consultato l'11 ottobre 2019.

nih.gov

ncbi.nlm.nih.gov

Rakheja D, Narayan SB, Bennett MJ, Juvenile neuronal ceroid-lipofuscinosis (Batten disease): a brief review and update, in Curr. Mol. Med., vol. 7, n. 6, settembre 2007, pp. 603–8, DOI:10.2174/156652407781695729, PMID 17896996. URL consultato il 1º novembre 2018 (archiviato dall'url originale il 15 aprile 2009).
CEROID LIPOFUSCINOSIS, NEURONAL, 3; CLN3 - OMIM Result, su ncbi.nlm.nih.gov. URL consultato il 5 agosto 2010.
Miao N, Levin SW, Baker EH, et al., Children with infantile neuronal ceroid lipofuscinosis have an increased risk of hypothermia and bradycardia during anesthesia, in Anesth. Analg., vol. 109, n. 2, agosto 2009, pp. 372–8, DOI:10.1213/ane.0b013e3181aa6e95, PMC 2743022, PMID 19608805. URL consultato il 5 agosto 2010.
Neuronal Ceroid-Lipofuscinoses [GeneReviews. 1993] - PubMed result, su ncbi.nlm.nih.gov. URL consultato il 1º agosto 2010.
HH. Goebel, T. Bilzer; E. Dahme; F. Malkusch, Morphological studies in canine (Dalmatian) neuronal ceroid-lipofuscinosis., in Am J Med Genet Suppl, vol. 5, 1988, pp. 127-39, PMID 3146312.
HH. Goebel, E. Dahme, Ultrastructure of retinal pigment epithelial and neural cells in the neuronal ceroid-lipofuscinosis affected Dalmatian dog., in Retina, vol. 6, n. 3, pp. 179-87, PMID 3025985.
DP. O'Brien, ML. Katz, Neuronal ceroid lipofuscinosis in 3 Australian shepherd littermates., in J Vet Intern Med, vol. 22, n. 2, pp. 472-5, DOI:10.1111/j.1939-1676.2008.0079.x, PMID 18371036.
DB. Sisk, DC. Levesque; PA. Wood; EL. Styer, Clinical and pathologic features of ceroid lipofuscinosis in two Australian cattle dogs., in J Am Vet Med Assoc, vol. 197, n. 3, agosto 1990, pp. 361-4, PMID 2391273.
M. Kuwamura, R. Hattori; J. Yamate; T. Kotani; K. Sasai, Neuronal ceroid-lipofuscinosis and hydrocephalus in a chihuahua., in J Small Anim Pract, vol. 44, n. 5, maggio 2003, pp. 227-30, PMID 12779175.
DN. Palmer, J. Tyynelä; HC. van Mil; VJ. Westlake; RD. Jolly, Accumulation of sphingolipid activator proteins (SAPs) A and D in granular osmiophilic deposits in miniature Schnauzer dogs with ceroid-lipofuscinosis., in J Inherit Metab Dis, vol. 20, n. 1, marzo 1997, pp. 74-84, PMID 9061571.
JH. Rossmeisl, R. Duncan; J. Fox; ES. Herring; KD. Inzana, Neuronal ceroid-lipofuscinosis in a Labrador Retriever., in J Vet Diagn Invest, vol. 15, n. 5, settembre 2003, pp. 457-60, PMID 14535546.
L. Minatel, SC. Underwood; JC. Carfagnini, Ceroid-lipofuscinosis in a Cocker Spaniel dog., in Vet Pathol, vol. 37, n. 5, settembre 2000, pp. 488-90, PMID 11055878.
A. Kirchhoff, C. Kobe, [Generalized ceroid lipofuscinosis in cocker spaniels], in Zentralbl Veterinarmed A, vol. 41, n. 10, dicembre 1994, pp. 731-40, PMID 7653111.
JS. Nimmo Wilkie, EB. Hudson, Neuronal and generalized ceroid-lipofuscinosis in a cocker spaniel., in Vet Pathol, vol. 19, n. 6, novembre 1982, pp. 623-8, PMID 6890736.
C. Drögemüller, A. Wöhlke; O. Distl, Evaluation of the canine TPP1 gene as a candidate for neuronal ceroid lipofuscinosis in Tibetan Terrier and Polish Owczarek Nizinny dogs., in Anim Genet, vol. 36, n. 2, aprile 2005, pp. 178-9, DOI:10.1111/j.1365-2052.2005.01254.x, PMID 15771740.
K. Narfström, A. Wrigstad, Clinical, electrophysiological, and morphological findings in a case of neuronal ceroid lipofuscinosis in the Polish Owczarek Nizinny (PON) dog., in Vet Q, 17 Suppl 1, aprile 1995, pp. S46, PMID 7571313.
SA. Melville, CL. Wilson; CS. Chiang; VP. Studdert; F. Lingaas; AN. Wilton, A mutation in canine CLN5 causes neuronal ceroid lipofuscinosis in Border collie dogs., in Genomics, vol. 86, n. 3, settembre 2005, pp. 287-94, DOI:10.1016/j.ygeno.2005.06.005, PMID 16033706.
H. Koie, H. Shibuya; T. Sato; A. Sato; K. Nawa; Y. Nawa; M. Kitagawa; M. Sakai; T. Takahashi; Y. Yamaya; O. Yamato, Magnetic resonance imaging of neuronal ceroid lipofuscinosis in a border collie., in J Vet Med Sci, vol. 66, n. 11, novembre 2004, pp. 1453-6, PMID 15585966.
RM. Taylor, BR. Farrow, Ceroid lipofuscinosis in the border collie dog: retinal lesions in an animal model of juvenile Batten disease., in Am J Med Genet, vol. 42, n. 4, febbraio 1992, pp. 622-7, DOI:10.1002/ajmg.1320420438, PMID 1319117.
VP. Studdert, RW. Mitten, Clinical features of ceroid lipofuscinosis in border collie dogs., in Aust Vet J, vol. 68, n. 4, aprile 1991, pp. 137-40, PMID 2069541.
RM. Taylor, BR. Farrow, Ceroid-lipofuscinosis in border collie dogs., in Acta Neuropathol, vol. 75, n. 6, 1988, pp. 627-31, PMID 3376765.
H. Shibuya, PC. Liu; ML. Katz; AN. Siakotos; DJ. Nonneman; GS. Johnson, Coding sequence and exon/intron organization of the canine CLN3 (Batten disease) gene and its exclusion as the locus for ceroid-lipofuscinosis in English setter dogs., in J Neurosci Res, vol. 52, n. 3, maggio 1998, pp. 268-75, PMID 9590435.
F. Lingaas, T. Aarskaug; M. Sletten; I. Bjerkås; U. Grimholt; L. Moe; RK. Juneja; AN. Wilton; F. Galibert; NG. Holmes; G. Dolf, Genetic markers linked to neuronal ceroid lipofuscinosis in English setter dogs., in Anim Genet, vol. 29, n. 5, ottobre 1998, pp. 371-6, PMID 9800325.
K. Kitani, M. Senda; H. Toyama; K. Miyasaka; S. Kanai; M. Ohta; GO. Ivy; N. Koppang, Decline in glucose metabolism in the brain in neuronal ceroid lipofuscinosis (NCL) in English setter--evidence by positron emission tomography (PET)., in Gerontology, 41 Suppl 2, 1995, pp. 249-57, PMID 8821336.
N. Koppang, English setter model and juvenile ceroid-lipofuscinosis in man., in Am J Med Genet, vol. 42, n. 4, febbraio 1992, pp. 599-604, DOI:10.1002/ajmg.1320420434, PMID 1609842.
N. Koppang, The English setter with ceroid-lipofuscinosis: a suitable model for the juvenile type of ceroid-lipofuscinosis in humans., in Am J Med Genet Suppl, vol. 5, 1988, pp. 117-25, PMID 3146311.
EC. Appleby, JA. Longstaffe; FR. Bell, Ceroid-lipofuscinosis in two Saluki dogs., in J Comp Pathol, vol. 92, n. 3, luglio 1982, pp. 375-80, PMID 6890561.
LB. Augestad, J. Diderichsen, [Neuronal ceroid lipofuscinoses], in Tidsskr Nor Laegeforen, vol. 126, n. 15, agosto 2006, pp. 1908-10, PMID 16915312.
JJ. Shacka, KA. Roth, Cathepsin D deficiency and NCL/Batten disease: there's more to death than apoptosis., in Autophagy, vol. 3, n. 5, pp. 474-6, PMID 17495518.
C. Pierret, JA. Morrison; MD. Kirk, Treatment of lysosomal storage disorders: focus on the neuronal ceroid-lipofuscinoses., in Acta Neurobiol Exp (Wars), vol. 68, n. 3, 2008, pp. 429-42, PMID 18668166.
D. Ramirez-Montealegre, PG. Rothberg; DA. Pearce, Another disorder finds its gene., in Brain, vol. 129, Pt 6, giugno 2006, pp. 1353-6, DOI:10.1093/brain/awl132, PMID 16738059.
JJ. Shacka, KA. Roth, Cathepsin deficiency as a model for neuronal ceroid lipofuscinoses., in Am J Pathol, vol. 167, n. 6, dicembre 2005, pp. 1473-6, PMID 16314462.
C. Hartzell, Z. Qu; I. Putzier; L. Artinian; LT. Chien; Y. Cui, Looking chloride channels straight in the eye: bestrophins, lipofuscinosis, and retinal degeneration., in Physiology (Bethesda), vol. 20, ottobre 2005, pp. 292-302, DOI:10.1152/physiol.00021.2005, PMID 16174869.
G. Anderson, VV. Smith; M. Malone; NJ. Sebire, Blood film examination for vacuolated lymphocytes in the diagnosis of metabolic disorders; retrospective experience of more than 2,500 cases from a single centre., in J Clin Pathol, vol. 58, n. 12, dicembre 2005, pp. 1305-10, DOI:10.1136/jcp.2005.027045, PMID 16311352.
CW. Lee, H. Bang; YG. Oh; HS. Yun; JD. Kim; CJ. Coe, A case of late infantile neuronal ceroid lipofuscinosis., in Yonsei Med J, vol. 44, n. 2, aprile 2003, pp. 331-5, PMID 12728477.
RS. Howard, DM. Kullmann; NP. Hirsch, Admission to neurological intensive care: who, when, and why?, in J Neurol Neurosurg Psychiatry, 74 Suppl 3, settembre 2003, pp. iii2-9, PMID 12933908.
H. Alonso-Navarro, FJ. Jiménez-Jiménez; I. Puertas-Muñoz; J. Rábano; JG. de Yébenes; JL. Sarasa-Corral, [Klüver-Bucy syndrome as the initial symptom of adult-type ceroid lipofuscinosis (Kufs' disease)], in Rev Neurol, vol. 40, n. 2, pp. 93-8, PMID 15712163.
RS. Howard, RW. Orrell, Management of motor neurone disease., in Postgrad Med J, vol. 78, n. 926, dicembre 2002, pp. 736-41, PMID 12509691.
JO. Sass, D. Skladal; M. Brunner-Krainz, Normal ascorbic acid in cerebrospinal fluid of patients with infantile neuronal ceroid-lipofuscinosis., in Metab Brain Dis, vol. 14, n. 1, marzo 1999, pp. 67-70, PMID 10348315.
P. Santavuori, H. Heiskala; T. Westermarck; K. Sainio; R. Moren, Experience over 17 years with antioxidant treatment in Spielmeyer-Sjögren disease., in Am J Med Genet Suppl, vol. 5, 1988, pp. 265-74, PMID 3146324.
S. Naidu, I. Maumanee; J. Olson; J. Borel; H. Moser, Selenium treatment in neuronal ceroid-lipofuscinosis., in Am J Med Genet Suppl, vol. 5, 1988, pp. 283-9, PMID 3146327.
S. Worgall, D. Sondhi; NR. Hackett; B. Kosofsky; MV. Kekatpure; N. Neyzi; JP. Dyke; D. Ballon; L. Heier; BM. Greenwald; P. Christos, Treatment of late infantile neuronal ceroid lipofuscinosis by CNS administration of a serotype 2 adeno-associated virus expressing CLN2 cDNA., in Hum Gene Ther, vol. 19, n. 5, maggio 2008, pp. 463-74, DOI:10.1089/hum.2008.022, PMID 18473686.
JD. Cooper, Moving towards therapies for juvenile Batten disease?, in Exp Neurol, vol. 211, n. 2, giugno 2008, pp. 329-31, DOI:10.1016/j.expneurol.2008.02.016, PMID 18400221.
AD. Kovács, DA. Pearce, Attenuation of AMPA receptor activity improves motor skills in a mouse model of juvenile Batten disease., in Exp Neurol, vol. 209, n. 1, gennaio 2008, pp. 288-91, DOI:10.1016/j.expneurol.2007.09.012, PMID 17963751.
G. Gigler, K. Móricz; M. Agoston; A. Simó; M. Albert; A. Benedek; G. Kapus; S. Kertész; M. Vegh; J. Barkóczy; B. Markó, Neuroprotective and anticonvulsant effects of EGIS-8332, a non-competitive AMPA receptor antagonist, in a range of animal models., in Br J Pharmacol, vol. 152, n. 1, settembre 2007, pp. 151-60, DOI:10.1038/sj.bjp.0707362, PMID 17603549.
PK. Aujla, MR. Fetell; FE. Jensen, Talampanel suppresses the acute and chronic effects of seizures in a rodent neonatal seizure model., in Epilepsia, vol. 50, n. 4, aprile 2009, pp. 694-701, DOI:10.1111/j.1528-1167.2008.01947.x, PMID 19220413.
SN. Rakhade, C. Zhou; PK. Aujla; R. Fishman; NJ. Sucher; FE. Jensen, Early alterations of AMPA receptors mediate synaptic potentiation induced by neonatal seizures., in J Neurosci, vol. 28, n. 32, agosto 2008, pp. 7979-90, DOI:10.1523/JNEUROSCI.1734-08.2008, PMID 18685023.
JF. Howes, C. Bell, Talampanel., in Neurotherapeutics, vol. 4, n. 1, gennaio 2007, pp. 126-9, DOI:10.1016/j.nurt.2006.11.001, PMID 17199027.
G. Siciliano, C. Carlesi; L. Pasquali; S. Piazza; S. Pietracupa; F. Fornai; S. Ruggieri; L. Murri, Clinical trials for neuroprotection in ALS., in CNS Neurol Disord Drug Targets, vol. 9, n. 3, luglio 2010, pp. 305-13, PMID 20406180.
RM. Pascuzzi, J. Shefner; AS. Chappell; JS. Bjerke; R. Tamura; V. Chaudhry; L. Clawson; L. Haas; JD. Rothstein, A phase II trial of talampanel in subjects with amyotrophic lateral sclerosis., in Amyotroph Lateral Scler, vol. 11, n. 3, maggio 2010, pp. 266-71, DOI:10.3109/17482960903307805, PMID 19961264.
L. Van Den Bosch, W. Vandenberghe; H. Klaassen; E. Van Houtte; W. Robberecht, Ca(2+)-permeable AMPA receptors and selective vulnerability of motor neurons., in J Neurol Sci, vol. 180, n. 1-2, novembre 2000, pp. 29-34, PMID 11090861.
BJ. Traynor, L. Bruijn; R. Conwit; F. Beal; G. O'Neill; SC. Fagan; ME. Cudkowicz, Neuroprotective agents for clinical trials in ALS: a systematic assessment., in Neurology, vol. 67, n. 1, luglio 2006, pp. 20-7, DOI:10.1212/01.wnl.0000223353.34006.54, PMID 16832072.
O. Hurko, FS. Walsh, Novel drug development for amyotrophic lateral sclerosis., in J Neurol Sci, vol. 180, n. 1-2, novembre 2000, pp. 21-8, PMID 11090860.
Neuronal Ceroid-Lipofuscinoses -- GeneReviews -- NCBI Bookshelf, su ncbi.nlm.nih.gov. URL consultato il 1º agosto 2010.
JY. Lu, LA. Verkruyse; SL. Hofmann, The effects of lysosomotropic agents on normal and INCL cells provide further evidence for the lysosomal nature of palmitoyl-protein thioesterase function., in Biochim Biophys Acta, vol. 1583, n. 1, giugno 2002, pp. 35-44, PMID 12069847.
JY. Lu, SL. Hofmann, Inefficient cleavage of palmitoyl-protein thioesterase (PPT) substrates by aminothiols: implications for treatment of infantile neuronal ceroid lipofuscinosis., in J Inherit Metab Dis, vol. 29, n. 1, febbraio 2006, pp. 119-26, DOI:10.1007/s10545-006-0225-z, PMID 16601878.

oadoi.org

Neuronal ceroid lipofuscinoses therapeutic strategies: Past, present and future, DOI:10.1016/j.bbadis.2006.08.004.
Experimental Neurology : Moving towards therapies for Juvenile Batten disease?, DOI:10.1016/j.expneurol.2008.02.016.
DP. O'Brien, ML. Katz, Neuronal ceroid lipofuscinosis in 3 Australian shepherd littermates., in J Vet Intern Med, vol. 22, n. 2, pp. 472-5, DOI:10.1111/j.1939-1676.2008.0079.x, PMID 18371036.
C. Drögemüller, A. Wöhlke; O. Distl, Evaluation of the canine TPP1 gene as a candidate for neuronal ceroid lipofuscinosis in Tibetan Terrier and Polish Owczarek Nizinny dogs., in Anim Genet, vol. 36, n. 2, aprile 2005, pp. 178-9, DOI:10.1111/j.1365-2052.2005.01254.x, PMID 15771740.
SA. Melville, CL. Wilson; CS. Chiang; VP. Studdert; F. Lingaas; AN. Wilton, A mutation in canine CLN5 causes neuronal ceroid lipofuscinosis in Border collie dogs., in Genomics, vol. 86, n. 3, settembre 2005, pp. 287-94, DOI:10.1016/j.ygeno.2005.06.005, PMID 16033706.
RM. Taylor, BR. Farrow, Ceroid lipofuscinosis in the border collie dog: retinal lesions in an animal model of juvenile Batten disease., in Am J Med Genet, vol. 42, n. 4, febbraio 1992, pp. 622-7, DOI:10.1002/ajmg.1320420438, PMID 1319117.
N. Koppang, English setter model and juvenile ceroid-lipofuscinosis in man., in Am J Med Genet, vol. 42, n. 4, febbraio 1992, pp. 599-604, DOI:10.1002/ajmg.1320420434, PMID 1609842.
S. Worgall, D. Sondhi; NR. Hackett; B. Kosofsky; MV. Kekatpure; N. Neyzi; JP. Dyke; D. Ballon; L. Heier; BM. Greenwald; P. Christos, Treatment of late infantile neuronal ceroid lipofuscinosis by CNS administration of a serotype 2 adeno-associated virus expressing CLN2 cDNA., in Hum Gene Ther, vol. 19, n. 5, maggio 2008, pp. 463-74, DOI:10.1089/hum.2008.022, PMID 18473686.
JD. Cooper, Moving towards therapies for juvenile Batten disease?, in Exp Neurol, vol. 211, n. 2, giugno 2008, pp. 329-31, DOI:10.1016/j.expneurol.2008.02.016, PMID 18400221.
AD. Kovács, DA. Pearce, Attenuation of AMPA receptor activity improves motor skills in a mouse model of juvenile Batten disease., in Exp Neurol, vol. 209, n. 1, gennaio 2008, pp. 288-91, DOI:10.1016/j.expneurol.2007.09.012, PMID 17963751.
PK. Aujla, MR. Fetell; FE. Jensen, Talampanel suppresses the acute and chronic effects of seizures in a rodent neonatal seizure model., in Epilepsia, vol. 50, n. 4, aprile 2009, pp. 694-701, DOI:10.1111/j.1528-1167.2008.01947.x, PMID 19220413.
SN. Rakhade, C. Zhou; PK. Aujla; R. Fishman; NJ. Sucher; FE. Jensen, Early alterations of AMPA receptors mediate synaptic potentiation induced by neonatal seizures., in J Neurosci, vol. 28, n. 32, agosto 2008, pp. 7979-90, DOI:10.1523/JNEUROSCI.1734-08.2008, PMID 18685023.
JF. Howes, C. Bell, Talampanel., in Neurotherapeutics, vol. 4, n. 1, gennaio 2007, pp. 126-9, DOI:10.1016/j.nurt.2006.11.001, PMID 17199027.
RM. Pascuzzi, J. Shefner; AS. Chappell; JS. Bjerke; R. Tamura; V. Chaudhry; L. Clawson; L. Haas; JD. Rothstein, A phase II trial of talampanel in subjects with amyotrophic lateral sclerosis., in Amyotroph Lateral Scler, vol. 11, n. 3, maggio 2010, pp. 266-71, DOI:10.3109/17482960903307805, PMID 19961264.
BJ. Traynor, L. Bruijn; R. Conwit; F. Beal; G. O'Neill; SC. Fagan; ME. Cudkowicz, Neuroprotective agents for clinical trials in ALS: a systematic assessment., in Neurology, vol. 67, n. 1, luglio 2006, pp. 20-7, DOI:10.1212/01.wnl.0000223353.34006.54, PMID 16832072.
JY. Lu, SL. Hofmann, Inefficient cleavage of palmitoyl-protein thioesterase (PPT) substrates by aminothiols: implications for treatment of infantile neuronal ceroid lipofuscinosis., in J Inherit Metab Dis, vol. 29, n. 1, febbraio 2006, pp. 119-26, DOI:10.1007/s10545-006-0225-z, PMID 16601878.

portlandtribune.com

"A stem cell first at OHSU Archiviato il 6 febbraio 2012 in Internet Archive." The Portland Tribune, Nov 24, 2006

rxlist.com

Cystagon (Cysteamine Bitartrate) Drug Information: Uses, Side Effects, Drug Interactions and Warnings at RxList, su rxlist.com. URL consultato il 1º agosto 2010.

technologyreview.com

https://www.technologyreview.com/read_article.aspx?id=17888&ch=biotech

ucl.ac.uk

NCL resource, su ucl.ac.uk. URL consultato il 1º agosto 2010.
NCL resource, su ucl.ac.uk. URL consultato il 3 agosto 2010.
www.ucl.ac.uk (PDF), su ucl.ac.uk. URL consultato il 5 agosto 2010.

web.archive.org

Rakheja D, Narayan SB, Bennett MJ, Juvenile neuronal ceroid-lipofuscinosis (Batten disease): a brief review and update, in Curr. Mol. Med., vol. 7, n. 6, settembre 2007, pp. 603–8, DOI:10.2174/156652407781695729, PMID 17896996. URL consultato il 1º novembre 2018 (archiviato dall'url originale il 15 aprile 2009).
What is Batten disease, late infantile, juvenile NCL? : Batten Disease Support and Research Association, su bdsra.org. URL consultato il 5 agosto 2010 (archiviato dall'url originale il 3 dicembre 2009).
What is Batten disease, late infantile, juvenile NCL? : Batten Disease Support and Research Association, su bdsra.org. URL consultato il 1º agosto 2010 (archiviato dall'url originale il 3 dicembre 2009).
"A stem cell first at OHSU Archiviato il 6 febbraio 2012 in Internet Archive." The Portland Tribune, Nov 24, 2006

webcitation.org

StemCells: Enter Date, su stemcellsinc.com (archiviato dall'url originale il 12 settembre 2012).